Abstract:Oropharyngeal candidiasis (OPC) is the most prevalent oral infection in immunocompromised patients, primarily associated with Candida albicans. Increasing evidence points to a significant role of mucosal bacteria on the transition of C. albicans from commensal to pathogenic. In this work, we hypothesized that changes in the abundance or composition of the mucosal bacterial microbiota induced by dietary sucrose during the development of OPC can modulate C. albicans virulence. C. albicans burdens and mucosal lesions were evaluated in a mouse cortisone immunosuppression model amended with sucrose. We also analyzed the mucosal bacterial composition using 16S rRNA gene sequencing and culture methods. In immunocompetent mice, sucrose significantly increased total bacterial burdens and reduced alpha diversity, by increasing the relative abundance of mitis group streptococci. In immunocompromised mice, C. albicans infection was associated with a significantly reduced bacterial alpha diversity due to an increase in the relative abundance of enterococci. When exposed to dietary sucrose, these mice had reduced C. albicans burdens and reduced bacterial alpha diversity, associated with an increase in the relative abundance of Lactobacillus. SparCC correlation networks showed a significant negative correlation between Lactobacillus and Enterococcus in all Candida-infected mice. Depletion of lactobacilli with antibiotic treatment partially restored C. albicans burdens in mice receiving sucrose. In coculture in vitro experiments, mouse oral Lactobacillus johnsonii isolates inhibited growth of Enterococcus faecalis isolates and C. albicans. These results support the hypothesis that the sucrose-induced attenuation of C. albicans virulence was a result of changes in the mucosal bacterial microbiome characterized by a reduction in enterococci and an increase in lactobacilli. IMPORTANCE By comparing Candida albicans virulence and the mucosal bacterial composition in a mouse oral infection model, we were able to dissect the effects of the host environment (immunosuppression), infection with C. albicans, and local modulating factors (availability of sucrose as a carbon source) on the mucosal bacterial microbiome and its role on fungal virulence. We showed that changes in endogenous microbial communities in response to sucrose can lead to attenuation of fungal disease. We also showed that Lactobacillus johnsonii may curtail Candida virulence both by inhibiting its growth and by inhibiting the growth of potentially synergistic bacteria such as enterococci. Our results support the concept that Candida pathogenesis should be viewed in the contexts of both a susceptible host and a mucosal bacterial microbiota conducive to virulence.

Experimental Study of Inhibiting Candida Albicans Infection by Saccharomyces Cerevisiae

The Impact of Intestinal Microbiota Imbalances on Susceptibility to Invasive Candida Albicans Infection in SCID Mice

Effectiveness of a Vaginal Antimicrobial Containing Double Live Microorganisms in the Treatment of Candidiasis Vaginitis and Gonococcus Vaginitis in Rabbits

Study for drug resistance and pathogenicity of proteinase of saccharomyces albicans in leucorrhea specimen

Immune Cross-Reactions Between Four Types of Candidas and Anti-Candida Serum

Protective ability of certain lactic acid bacteria against an infection with Candida albicans in a mouse immunosuppression model by corticoid

Oral Treatment with Saccharomyces cerevisiae CNCM I-3856 Mitigates the Inflammatory Response Experimentally Induced by Salmonella enterica subsp. enterica Serovar Typhimurium in Mice

Multi-Step Pathogenesis and Induction of Local Immune Response by Systemic Candida Albicans Infection in an Intravenous Challenge Mouse Model

Establishment and evaluation of invasive Candida albicans infection model in mice

Establishment of a model of systemic Candida infection in immuno-suppressed mice via intraperitoneal injection

Efficacy Of Cg(3)R(6)Tat Nanoparticles Self-Assembled From A Novel Antimicrobial Peptide For The Treatment Of Candida Albicans Meningitis In Rabbits

Effects of Candida Albicans Infection on Defense Effector Secretion by Human Oral Mucosal Epithelial Cells.

Capability of Iturin from Bacillus Subtilis to Inhibit Candida Albicans in Vitro and in Vivo

Inhibition of Candida albicans in vivo and in vitro by antimicrobial peptides chromogranin A-N12 through microRNA-155/suppressor of cytokine signaling 1 axis

Influence of Ascorbic Acid Supplementation on Systemic Candidiasis in Mice

The Promotional Effect of GW4869 on C. albicans Invasion and Cellular Damage in A Murine Model of Oral Candidiasis

Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

Saccharomyces cerevisiae SC-2201 Attenuates AOM/DSS-Induced Colorectal Cancer by Modulating the Gut Microbiome and Blocking Proinflammatory Mediators

Effect of Cinnamaldehyde on Systemic Candida albicans Infection in Mice

Effects of Boric Acid Gel on Vaginal Candida albicans Infections and the Local Immune System in Mice